article thumbnail

Low oxygen levels restore balance and coordination in a mouse model of a movement disorder

Broad Institute

said Vamsi Mootha , senior author of the study, an institute member at the Broad, professor of systems biology and medicine at Harvard Medical School, and professor of molecular biology at Massachusetts General Hospital. Mootha’s lab has been studying hypoxia as a potential treatment for rare neurological diseases since 2016.

article thumbnail

Michael Crichton and James Patterson’s “Eruption” is Riveting, but with a Shaky Genetic Foundation

PLOS: DNA Science

The tale opens at the Hilo Botanical Gardens in 2016. And there the herbicide sat, until in 2016, workers attempting to repackage and seal the material instead caused a leak. TMV is a common pathogen used in early molecular biology research. Newbie chief plant biologist Rachel Sherrill (named for Crichton’s wife?)

DNA 52
article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. Bioinformatics is all about bringing together different areas of knowledge.

article thumbnail

Otto Bayer Award goes to Prof. Ruth Ley PhD

The Pharma Data

Born in 1970, the British and American research scientist has been Director of the Department of Microbiome Research at the Max Planck Institute for Developmental Biology in Tübingen since 2016. Before, she was associate professor at Cornell University in the Department of Molecular Biology and Genetics.

article thumbnail

SRP-001: redefining pain treatment with a safer, non-opioid analgesic

Drug Target Review

was founded in 2016 to develop safer, non-opioid therapies for acute and chronic pain. Dr Hernan Bazan received a BS in molecular biology from Vanderbilt University and has spent two years in medical school as a Howard Hughes Medical Institute (HHMI) Research Scholar at the NIH. South Rampart Pharma, Inc.

article thumbnail

Alzheimer’s disease: driving advancements with precision medicine

Drug Target Review

2016, August 2). Progress in molecular biology and translational science. Blennow, K., Carrillo, M. Feldman, H. Frisoni, G. Jagust, W. Johnson, K. Knopman, D. Petersen, R. Scheltens, P., Sperling, R. A., & Dubois, B. A/t/N: An unbiased descriptive classification scheme for alzheimer disease biomarkers. link] Cousins, K.

Disease 59